CLARUS THERAPEUTICS HOLDINGS (CRXT) Stock Cash Flow
NASDAQ:CRXT - Nasdaq - US18271L1070 - Common Stock - Currency: USD
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -66.14M | -40.62M | 4.34M | -41.65M | |||
| Depreciation Amortization | N/A | 25.00K | 18.00K | 4.00K | |||
| Change In Working Capital | -5.94M | -7.25M | 7.66M | -2.28M | |||
| Interest Paid | N/A | 0.00 | 3.13M | 0.00 | |||
| Other non cash items | 11.21M | 4.05M | -53.61M | 24.21M | |||
| OPERATING CASH FLOW | -60.82M | -43.79M | -41.58M | -19.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | N/A | -25.00K | -63.00K | -21.00K | |||
| Other Investing Activity | N/A | N/A | -58.65M | N/A | |||
| INVESTING CASH FLOW | N/A | -25.00K | -63.00K | -21.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | N/A | 32.18M | 50.74M | 18.39M | |||
| Stock Issued/Repurchased | N/A | 13.80M | 60.95M | N/A | |||
| Other Financing Activity | N/A | 17.01M | -3.52M | -29.00K | |||
| FINANCING CASH FLOW | 63.01M | 62.99M | 47.22M | 18.36M | |||
| CHANGE IN CASH | 2.15M | 19.18M | 5.58M | -1.38M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -60.82M | -43.79M | -41.58M | -19.71M | |||
| Capital Expenditure | N/A | -25.00K | -63.00K | -21.00K | |||
| FREE CASH FLOW | N/A | -43.81M | -41.64M | -19.74M | |||
All data in USD